ACTRN12614000809639已完成1 期
Single-centre, single-dose, open-label, randomised, five-way cross-over study to evaluate the pharmacokinetic parameters of intravenously administered combination of paracetamol and ibuprofen, intravenous paracetamol, intravenous ibuprofen and fixed dose combination tablets of paracetamol and ibuprofen, in healthy volunteers.
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 50 Years（—）
- 性别
- All
入选标准
- •Healthy volunteers
排除标准
- •Pregnancy, nursing, drug abuse, smoking > 10 cigarettes per day, excess alcohol intake, prescription drugs within 14 days of the study, participating in another trial within 80 days, clinically significant abnormal lab tests.
研究者
相似试验
已完成
1 期
Pharmacokinetic study of acetaminophen and ibuprofen, oral formulations, in healthy volunteers under fed conditionsACTRN12616000317493AFT Pharmaceuticals Ltd.30
已完成
1 期
Maxigesic Metabolism Study: To describe the metabolism of paracetamol when combined with ibuprofen in healthy adult volunteers.ACTRN12612000871842AFT Pharmacetuicals Ltd12
已完成
1 期
Exploratory Phase 1 pharmacokinetic study of different doses of paracetamol plus ibuprofen under fasting and fed conditionsPharmacokinetic studyOther - Research that is not of generic health relevance and not applicable to specific health categories listed aboveACTRN12613000887774AFT Pharmaceuticals Ltd28
已完成
1 期
Phase I Pharmacokinetic study evaluating the pharmacokinetic profile of a fixed dose combination product (1000 mg paracetamol + 300 mg ibuprofen) under fasting and fed conditionsPharmacokinetic studyOther - Research that is not of generic health relevance and not applicable to specific health categories listed aboveACTRN12613001151729AFT Pharmaceuticals Ltd28
已完成
不适用
Single-centre, randomised, prospective, open-label, three-period, Phase 1 clinical trial for assessment of the pharmacodynamic and pharmacokinetic interaction of remimazolam and remifentanilgeneral anesthesiasedationunconsiousnessNL-OMON51001PAION UK Limited24